Add BrightSurf on Google Email

Drug-resistance mutations in malaria

11.12.18 | Proceedings of the National Academy of Sciences
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Researchers report that in vitro selection for resistance to the drug artemisinin in two West African malaria strains yielded previously unidentified mutations conferring artemisinin resistance in the gene for PfCoronin, a conserved actin-binding protein with structural similarities to another protein implicated in artemisinin resistance, PfKelch13, providing potential insights into molecular mechanisms of artemisinin resistance.

###

Article #18-12317: "Mutations in Plasmodium falciparum actinbinding protein coronin confer reduced artemisinin susceptibility," by Allison R. Demas et al.

MEDIA CONTACT: Dyann F. Wirth, Harvard T.H. Chan School of Public Health, Boston, MA; tel: 617-432-2214; e-mail: < dfwirth@hsph.harvard.edu >

Proceedings of the National Academy of Sciences

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
Proceedings of the National Academy of Sciences. (2018, November 12). Drug-resistance mutations in malaria. Brightsurf News. https://www.brightsurf.com/news/L554R39L/drug-resistance-mutations-in-malaria.html
MLA:
"Drug-resistance mutations in malaria." Brightsurf News, Nov. 12 2018, https://www.brightsurf.com/news/L554R39L/drug-resistance-mutations-in-malaria.html.